Uniphar plc (LON:UPR - Get Free Report)'s share price reached a new 52-week high on Thursday . The company traded as high as GBX 306 ($4.15) and last traded at GBX 306 ($4.15), with a volume of 244527 shares traded. The stock had previously closed at GBX 296 ($4.01).
Wall Street Analyst Weigh In
Separately, Shore Capital reissued a "buy" rating on shares of Uniphar in a research report on Thursday.
Read Our Latest Stock Report on UPR
Uniphar Price Performance
The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The stock has a market cap of £952.52 million, a price-to-earnings ratio of 21.28 and a beta of 0.75. The stock has a 50-day moving average price of GBX 253.80 and a two-hundred day moving average price of GBX 213.33.
About Uniphar
(
Get Free Report)
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Recommended Stories
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
